4.8 Editorial Material

Caloric restriction mimetics: natural/physiological pharmacological autophagy inducers

Journal

AUTOPHAGY
Volume 10, Issue 11, Pages 1879-1882

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/auto.36413

Keywords

acetyl-coenzyme A; acetyl transferase; acetylation; deacetylase; deacetylation

Categories

Funding

  1. Ligue contre le Cancer (equipe labelisee)
  2. Agence Nationale de la Recherche (ANR)
  3. Association pour la recherche sur le cancer (ARC)
  4. Canceropole Ile-de-France
  5. Institut National du Cancer (INCa)
  6. Fondation Bettencourt-Schueller
  7. Fondation de France
  8. Fondation pour la Recherche Medicale (FRM)
  9. European Commission (ArtForce)
  10. European Research Council (ERC)
  11. LabEx Immuno-Oncology
  12. SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
  13. SIRIC Cancer Research and Personalized Medicine (CARPEM)
  14. Paris Alliance of Cancer Research Institutes (PACRI)
  15. FWF grants LIPOTOX [P23490-B12, I1000, P24381-B20]
  16. Austrian Science Fund (FWF) [P24381, P23490] Funding Source: Austrian Science Fund (FWF)
  17. Austrian Science Fund (FWF) [P 23490, P 24381] Funding Source: researchfish

Ask authors/readers for more resources

Nutrient depletion, which is one of the physiological triggers of autophagy, results in the depletion of intracellular acetyl coenzyme A (AcCoA) coupled to the deacetylation of cellular proteins. We surmise that there are 3 possibilities to mimic these effects, namely (i) the depletion of cytosolic AcCoA by interfering with its biosynthesis, (ii) the inhibition of acetyltransferases, which are enzymes that transfer acetyl groups from AcCoA to other molecules, mostly leucine residues in cellular proteins, or (iii) the stimulation of deacetylases, which catalyze the removal of acetyl groups from leucine residues. There are several examples of rather nontoxic natural compounds that act as AcCoA depleting agents (e.g., hydroxycitrate), acetyltransferase inhibitors (e.g., anacardic acid, curcumin, epigallocatechin-3-gallate, garcinol, spermidine) or deacetylase activators (e.g., nicotinamide, resveratrol), and that are highly efficient inducers of autophagy in vitro and in vivo, in rodents. Another common characteristic of these agents is their capacity to reduce aging-associated diseases and to confer protective responses against ischemia-induced organ damage. Hence, we classify them as caloric restriction mimetics (CRM). Here, we speculate that CRM may mediate their broad health-improving effects by triggering the same molecular pathways that usually are elicited by long-term caloric restriction or short-term starvation and that imply the induction of autophagy as an obligatory event conferring organismal, organ- or cytoprotection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available